Cellular immunity impaired among patients on left ventricular assist device for 6 months. Invited commentary.
Conte
John
J
Division of Cardiac Surgery, Johns Hopkins Medical Institutions, Blalock 618, 600 N. Wolfe St, Baltimore, MD 21287, USA. jconte@csurg.jhmi.jhu.edu
D003428:Cross Infection / Q000276:immunology* / Q000401:mortality; D015536:Down-Regulation / Q000276:immunology; D005500:Follow-Up Studies; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007111:Immunity, Cellular / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D013530:Surgical Wound Infection / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate; D016176:T-Lymphocyte Subsets / Q000276:immunology*